Skip to main content

Alzheimer's Cases to Triple by 2050


New estimates suggest that there were 4.7 million individuals aged 65 years or older with Alzheimer's disease dementia in the US in 2010 and that this number will triple to 13.8 million by 2050.
These latest estimates, published online February 6 inNeurology, were devised by a team from the Rush Institute for Healthy Aging, Chicago, Illinois.
"These are staggering numbers," coauthor Jennifer Weuve, MPH, ScD, commented to Medscape Medical News. "The ramifications for society and family caregivers in particular are huge."
"This is not really a surprise," she added. "It's a bit like climate change. We've known about it for years but we haven't done much to stop it. Our data drum home the message that research into the prevention and treatment of Alzheimer's must be a priority, as well as developing better ways of managing patients with the condition and helping caregivers."
A Complicated Task
Weuve explained that trying to estimate the number Alzheimer's cases in the country is a complicated task because medical and public health agencies are not good at documenting these statistics. In addition, Alzheimer's is hugely underdiagnosed.
She elaborated: "A diagnosis of Alzheimer's requires that you show up in a clinic and a physician actually thinks about dementia. Many patients go to their primary care doctor for something else, and although they may come across as confused, the doctor just puts this down to age and never formally diagnoses Alzheimer's, so about half of Alzheimer's cases go undiagnosed. Because of this, we had to be resourceful when trying to work out how many cases there actually were."
To get around this problem, Weuve and her colleagues based their estimates on a sample of 10,000 older adults, aged 65 years and older, who actually underwent neurologic testing as part of the Chicago Health and Aging Project, a longitudinal, population-based study.
They then worked out the prevalence of Alzheimer's disease according to age, sex, educational level, and race. By using US census data, this information was translated to the national population of the United States.
Of the 4.7 million individuals with Alzheimer's in 2010, the researchers estimated that 0.7 million were 65 to 74 years, 2.3 million were 75 to 84 years, and 1.8 million were 85 years or older.
With further use of census data, they then calculated how the older adult population will change over the next 40 years, and applied the 2010 prevalence data to future populations.
This gave an estimate of 13.8 million people with Alzheimer's in 2050, of whom 7 million would be aged 85 years or older.
This work was funded by the Alzheimer's Association and a grant from National Institutes of Health/National Institute on Aging. The authors have disclosed no relevant financial relationships.

Comments

Post a Comment

Popular posts from this blog

Early Surgery for Sigmoid Volvulus May be Safe and Effective

August 29, 2012 — Early elective surgery for sigmoid volvulus should be encouraged because it is associated with lower morbidity and mortality, as well as a lower incidence of recurrence, than conservative treatment, according to the findings of a retrospective study. Omid Yassaie, MBChB, from Tauranga Hospital in New Zealand, and colleagues presented their findings in an article published online August 24 in the ANZ Journal of Surgery. The authors remark that the optimal treatment of sigmoid volvulus and the long-term prognosis of patients after treatment are unclear. "Sigmoidoscopic treatment has gained favour as it is less invasive than surgery; however, a significant portion of patients return with recurrent volvulus," the authors write. "There is little, if any data in New Zealand or Australia on long-term follow-up of sigmoid volvulus." The authors analyzed 57 patients (from a total of 84 admissions for sigmoid volvulus) who were admitted to the Department o…
Post a Comment
Read more

Secondary Prevention: Clinical Approaches to Managing the Higher-Risk Patient with Heart Disease

INCIDENCE/PREVALENCE/BURDENS ASSOCIATED WITH CARDIOVASCULAR DISEASE (CVD) The prevention of an initial and recurrent cardiovascular event and other complications, such as diabetes and kidney failure [also known as end-stage renal disease (ESRD) or chronic kidney disease (CKD) stage 5] is an important goal in patients with a history of CVD. Each year, approximately 185,000 Americans suffer a recurrent stroke, approximately 470,000 will have a recurrent coronary attack, and an estimated 325,000 will suffer a recurrent myocardial infarction.[1] Secondary prevention strategies offer the opportunity to prevent further complications and improve outcomes by early detection and management of common comorbidities. The burden on public health and the costs associated with chronic illnesses such as CVD, CKD, and diabetes remain high. An estimated 82.6 million American adults (1 in 3) have 1 or more types of CVD.[1] Heart failure is the fastest-growing clinical cardiac disease entity in the Unit…
Post a Comment
Read more

Sexsomnia: Clinical Analysis of an Underdiagnosed Parasomnia

Introduction Sexsomnia, also known as sleep sex or somnambulistic sexual behavior, refers to unintentional sexual behaviors or activities during sleep. Sexsomnia is a relatively new diagnosis. The term was coined by Shapiro and colleagues in 2003,[1] but cases of this condition have been reported in the literature for the past 3 decades.[2,3] Sexual behavior during sleep automatism can range from explicit vocalizations to touching or sexual intercourse, and in some cases even sexual assault or rape. It is non-rapid eye movement (NREM) parasomnia characterized by abnormal transitions between sleep and wake states. The second edition of the International Classification of Sleep Disorders (ICSD-2) discusses somnambulistic sexual activity in the context of disorders of arousal from NREM sleep.[4] Most commonly, NREM parasomnias arise from slow-wave sleep (SWS). Because of a relative lack of cortical control, partial arousals from this deep state of sleep can lead to uninhibited manifesta…
Post a Comment
Read more